Stock Consolidation Decision (5:1 Ratio) and Correction Notice
- Stock consolidation decision: merge at a 5:1 ratio, changing par value from KRW 100 to KRW 500 (5 old shares → 1 new share)
- Total common shares decrease from 27,887,050 to 5,575,074 (corrected from previous 5,577,410)
- Purpose: stabilize stock price and enhance corporate value by maintaining appropriate number of shares in circulation
- Schedule: trading halt from 2026.04.14 to 2026.05.14, new shares listing on 2026.05.15
- Fractional shares to be paid in cash based on closing price on the first listing day
- This is not a capital reduction (no decrease in capital)
- Subject to special resolution at shareholders' meeting and may change due to regulatory consultations
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Decision on Stock Consolidation
- Company: KMPHARMACEUTICAL (225430)
- Submission: KMPHARMACEUTICAL Co.,Ltd.
- Receipt: 05-04-2026
- Under KRX KOSDAQ Market Division